Cannabinoid · Phytocannabinoid
Cannabitriol (CBT) is a phytocannabinoid made by the cannabis plant, in the CBT-type group. A small, poorly characterised class of cannabinoids.
Where it fits
Cannabitriol (CBT) sits in the CBT-type group. See the Phytocannabinoids index for how it relates to the rest of the family.
What the research shows
Direct human research on Cannabitriol (CBT) is minimal; it is characterised mainly by its chemistry and its place in the cannabinoid family rather than by clinical studies. We flag that plainly rather than overstate it.
FAQ
Is CBT intoxicating? No. Cannabitriol (CBT) is non-intoxicating.
How is cannabitriol (CBT) formed in cannabis? CBT forms as an oxidative degradation product of THC via epoxidation and diol hydroxylation at the C-9 and C-10 positions.
How many stereoisomers of CBT exist? Cannabitriol occurs in multiple stereoisomeric forms, including (+)- and (-)-cis and trans-9,10-dihydroxy variants as well as propyl and pentyl side-chain homologs.
Vicinal Diol Stereoisomers, X-Ray Crystal Structure, and Oxidative Formation
Cannabitriol (CBT, C21H30O4) is a hydroxylated cannabinoid first isolated from Japanese hemp by Obata and Ishikawa in 1966 and structurally determined by X-ray crystallography as a 9,10-dihydroxy derivative of THC (McPhail et al., 1976, PubMed PMID 952524). Subsequent isolation studies characterized both (+)- and (-)-cis and trans stereoisomers of cannabitriol along with homologs bearing C3 and C5 side chains, arising via epoxidation and diol ring-opening of THC double bonds alongside CBN (ElSohly et al., 1977, PubMed PMID 320426; Hanuš et al., 2016, PubMed PMID 28861498).
Part of the NOIDS cannabinoids index. Educational reference, not medical advice.